Recent research has shown that the formation of highly synapto-/neurotoxic soluble Aβ oligomers is triggered by a specific form of Aβ called pyroglutamate-Aβ (pGlu-Aβ) 1. Probiodrug’s focus ...

The Boston biotech said the platform had enabled the development of ALIA-1758 – an anti-pyroglutamate amyloid beta (Aβ3pE) antibody, which it says is a 'potential best-in-class therapy for ...

Aliada's lead compound, ALIA-1758, an anti-pyroglutamate amyloid beta (3pE-Aβ) antibody, is a potential best-in-class therapy for Alzheimer's disease Acquisition also allows AbbVie to utilize Aliada's ...

Aliada's lead compound, ALIA-1758, an anti-pyroglutamate amyloid beta (3pE-Aß) antibody, is a potential best-in-class therapy for Alzheimer's disease Acquisition also allows AbbVie to utilize ...